Kavita V Dharmarajan

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma
    Kavita V Dharmarajan
    Department of Radiation Oncology, Memorial Sloan Kettering, New York, New York 10065, USA
    Int J Radiat Oncol Biol Phys 84:996-1002. 2012
  2. doi Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study
    Kavita V Dharmarajan
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Pediatr Blood Cancer 60:242-7. 2013
  3. doi Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography
    Dana L Casey
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
    Int J Radiat Oncol Biol Phys 90:1136-42. 2014
  4. doi Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma
    Joanna C Yang
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 USA
    Int J Radiat Oncol Biol Phys 84:e371-7. 2012
  5. pmc Patterns of Relapse From a Phase 3 Study of Response-Based Therapy for Intermediate-Risk Hodgkin Lymphoma (AHOD0031): A Report From the Children's Oncology Group
    Kavita V Dharmarajan
    Mount Sinai Medical Center, New York, New York
    Int J Radiat Oncol Biol Phys 92:60-6. 2015

Collaborators

Detail Information

Publications5

  1. doi Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma
    Kavita V Dharmarajan
    Department of Radiation Oncology, Memorial Sloan Kettering, New York, New York 10065, USA
    Int J Radiat Oncol Biol Phys 84:996-1002. 2012
    ..We investigated whether primary-site treatment response characterized by serial PET imaging at specific time points can be correlated with local control...
  2. doi Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study
    Kavita V Dharmarajan
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Pediatr Blood Cancer 60:242-7. 2013
    ..We examined local control and toxicities in RMS patients treated with radiotherapy (RT) in combination with radiosensitizing agents irinotecan + carboplatin (I + C)...
  3. doi Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography
    Dana L Casey
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
    Int J Radiat Oncol Biol Phys 90:1136-42. 2014
    ..To evaluate whether [(18)F]fluorodeoxyglucose positron emission tomography (FDG-PET) response of the primary tumor after induction chemotherapy predicts outcomes in rhabdomyosarcoma (RMS)...
  4. doi Intensity modulated radiation therapy with dose painting to treat rhabdomyosarcoma
    Joanna C Yang
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 USA
    Int J Radiat Oncol Biol Phys 84:e371-7. 2012
    ..To examine local control and patterns of failure in rhabdomyosarcoma patients treated with intensity modulated radiation therapy (RT) with dose painting (DP-IMRT)...
  5. pmc Patterns of Relapse From a Phase 3 Study of Response-Based Therapy for Intermediate-Risk Hodgkin Lymphoma (AHOD0031): A Report From the Children's Oncology Group
    Kavita V Dharmarajan
    Mount Sinai Medical Center, New York, New York
    Int J Radiat Oncol Biol Phys 92:60-6. 2015
    ..The study was designed to determine whether response-based therapy improves outcomes in intermediate-risk Hodgkin lymphoma. We examined patterns of first relapse in the study...